Analysts expect Whitehawk Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00, a 100.0% beat against the -333,978.75 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 7.21 M | 7.24 M | 7.14 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 7.48 M | 7.90 M | 0.00 | 49.60 M | 0.00 | 0.00 | 0.00 | -305,457.63 | 0.00 | 0.00 | 0.00 | 0.00 | -766,437.22 | -943,221.92 | 499,772.95 | 203,472.63 | ||||||||||
| Low Estimate | 6.49 M | 7.33 M | 0.00 | 46.53 M | 0.00 | 0.00 | 0.00 | -362,499.87 | 0.00 | 0.00 | 0.00 | 0.00 | -848,183.88 | -1.06 M | 421,278.21 | 180,113.03 | ||||||||||
| Consensus Estimate | 6.99 M | 7.61 M | 0.00 | 48.07 M | 0.00 | 0.00 | 0.00 | -333,978.75 | 0.00 | 0.00 | 0.00 | 0.00 | -807,310.55 | -1.00 M | 460,525.58 | 191,792.83 |
Analysts expect Whitehawk Therapeutics, Inc. to report earnings per share of -0.21 for Q3 26, against a range of -0.22 to -0.20. The most recent reported quarter, Q2 26, came in at -0.20, a 31.0% beat against the -0.29 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.46 | -0.67 | 1.83 | -0.76 | -0.26 | -0.34 | -0.32 | -0.20 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.39 | -0.29 | -0.45 | 0.89 | 0.07 | -0.48 | -0.34 | -0.26 | -0.20 | -0.20 | -0.20 | -0.22 | -0.09 | -0.13 | -0.08 | -0.44 | ||||||||||
| Low Estimate | -0.47 | -0.31 | -0.53 | 0.83 | 0.07 | -0.54 | -0.40 | -0.32 | -0.22 | -0.22 | -0.22 | -0.26 | -0.11 | -0.13 | -0.10 | -0.52 | ||||||||||
| Consensus Estimate | -0.43 | -0.30 | -0.49 | 0.86 | 0.07 | -0.51 | -0.37 | -0.29 | -0.21 | -0.21 | -0.21 | -0.24 | -0.10 | -0.13 | -0.09 | -0.48 |
Pull Wall Street consensus for Whitehawk Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=WHWK&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "WHWK", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=WHWK&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();